FIELD: medicine, pharmacotherapy, neurology.
SUBSTANCE: for the purpose to prevent either urgent or constant treating migraine one should apply racemic alpha-lipoic acid as active substance or its enantiomers or pharmaceutically acceptable salts, amides, ethers, or thio ethers either in reduced or oxidized form. Application of racemic alpha-lipoic acid enables to increase efficiency of therapy.
EFFECT: improved results in treating migraine.
10 cl, 2 ex, 1 tbl
Authors
Dates
2004-07-20—Published
2000-08-26—Filed